Clinical Trial Update: Effect of Ranolazine on Valvular Disease in Patients With Pacemakers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the effect of ranolazine for ischemic mitral regurgitation in patients with pacemakers. The current status of the trial is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Mitral Regurgitation

Drugs mentioned

• Ranexa (ranolazine)

Snippet

Sponsor: University Cardiology | Conditions: Ischemic Mitral Regurgitation | Phase 4 | Status: UNKNOWN